Home›Stock Screener›Bajaj HealthCare

Bajaj HealthCare Share Price Today | Stock Price & Bajaj HealthCare Share Screener

BAJAJHCARE Pharmaceuticals
Live Share Price NSE
₹319.10
▼ -3.85 (-1.19%)
2026-10-05 00:00:00
Live Share Price BSE
₹319.05
▼ -4.35 (-1.35%)
2026-10-05 00:00:00

As of October 5, 2026, the live Bajaj HealthCare share price (NSE: BAJAJHCARE) is ₹319.10 on NSE and ₹319.05 on BSE, down 1.19% from the previous close, with shares trading between ₹317.10 and ₹329.00 in today's trading session, and a 52-week range of ₹274.95–₹481.00. Check BAJAJHCARE annual price range for the annual price range and momentum. Use the Bajaj HealthCare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Bajaj HealthCare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹635 and net income of ₹18, with EBITDA of ₹78, an operating margin of 11.0% and a profit margin of 2.8%.

Bajaj HealthCare Market Cap ₹1,137.80 Cr.
BAJAJHCARE P/E Ratio (TTM) 64.35
Bajaj HealthCare P/B Ratio 2.13
EPS (TTM) ₹4.98
Dividend Yield 0.44%
Debt to Equity 0.47
BAJAJHCARE 52 Week High ₹481.00
Bajaj HealthCare 52 Week Low ₹274.95
Operating Margin 11.00%
Profit Margin 2.83%
BAJAJHCARE Revenue (TTM) ₹635.00
EBITDA ₹78.00
Net Income ₹18.00
Total Assets ₹923.00
Total Equity ₹533.00

Bajaj HealthCare Share Price Chart

Track the current stock price of Bajaj HealthCare with an interactive chart. Analyse BAJAJHCARE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Bajaj HealthCare stock quote in one place.

The quote of ₹319.10 sits between the 52-week low of ₹274.95 and the 52-week high of ₹481.00, and the latest session moved -1.19% from the previous close.

Bajaj HealthCare Company Profile - Fundamental Screener

Screen Bajaj HealthCare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BAJAJHCARE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE411U01027.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE411U01027

Bajaj HealthCare Balance Sheet Screener

Screen BAJAJHCARE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹923, up from ₹833 in 2025.

Latest statistics put total assets at ₹923 and shareholder funds at ₹533, with a leverage ratio of 0.47.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 923 833 765 898 721 526 343 283 268 219
Current Assets 569 485 405 500 398 258 168 124 140 91
Fixed Assets 248 238 253 366 270 208 162 156 127 128

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 80 95 85 96 71 85 27 19 23 28
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 533 466 278 368 329 258 178 153 114 99
Share Capital 17 16 14 14 14 14 14 7 7 7
Reserves & Surplus 516 433 265 354 315 245 164 146 107 92

Bajaj HealthCare Income Statement Screener - Profit & Revenue Analysis

Screen Bajaj HealthCare income statement and profit fundamentals. Analyze BAJAJHCARE quarterly results. Bajaj HealthCare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹635 and net profit was ₹18, equal to earnings per unit of ₹5.40, at an operating margin of 11%.

In that period expenses were ₹558, interest cost ₹23 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹618 and net profit of ₹21.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 635 618 562 482 647 681 664 417 371 329 233 223 218
Expenses 558 506 460 397 534 561 521 362 328 288 200 193 190

Operating Costs and Margins

EBITDA 78 112 102 85 113 120 143 55 44 41 33 30 29
Operating Profit % 11.00% 17.00% 15.00% 16.00% 17.00% 17.00% 21.00% 12.00% 12.00% 12.00% 13.00% 13.00% 13.00%
Depreciation 29 28 28 28 17 18 16 12 11 11 11 9 9
Interest 23 22 28 30 18 13 8 6 8 8 8 8 8

Profit and Earnings

Profit Before Tax 25 29 46 -17 78 90 119 36 24 23 14 14 12
Tax 0 8 3 -2 15 18 36 11 8 8 6 5 5
Net Profit 18 21 43 -14 64 71 83 25 16 15 8 8 8
EPS 5.40 4.98 13.29 -30.36 15.59 25.87 30.11 18.29 11.82 22.01 11.37 12.15 11.13

Bajaj HealthCare Cash Flow Screener - Liquidity Fundamentals

Screen BAJAJHCARE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹58, and net cash flow was an inflow of ₹35.

Over the same period, investing activities used ₹48 and financing activities provided ₹24.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 58 22 92 -22 1 44 21 25 17 22
Investing Activities -48 -15 -11 -93 -75 -109 -28 -13 -12 -8

Financing and Net Cash

Financing Activities 24 -6 -97 131 62 76 3 -13 3 -13
Net Cash Flow 35 0 -16 16 -12 10 -4 0 7 1

Bajaj HealthCare Shareholding Pattern Screener

See Bajaj HealthCare shareholding pattern with promoter, FII, and DII holdings. Check Bajaj HealthCare promoter holding and ownership changes for BAJAJHCARE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 58.29%, foreign institutions 1.98%, domestic institutions 2.91% and the public 28.49%, spread across 37,696 shareholders.

The shareholder count was 37,696 in 2026-Mar, compared with 41,310 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 58.29% 58.59% 59.19% 59.19% 59.19% 59.19% 67.73% 67.73%

Institutional Investors

FII Holding 1.98% 2.19% 1.05% 1.09% 1.12% 1.18% 0.53% 0.01%
DII Holding 2.91% 1.92% 2.52% 3.16% 3.00% 2.96% 0.44% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 28.49% 29.81% 26.72% 26.63% 26.24% 26.62% 19.91% 20.17%
Other Holding 8.33% 7.48% 10.52% 9.93% 10.45% 10.05% 11.39% 12.09%
Shareholder Count 37,696 41,310 35,710 35,980 38,574 37,951 32,712 32,397

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Bajaj HealthCare. Bajaj HealthCare dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹1.50 per unit for 2026-March, a yield of 0.45%, compared with ₹1.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹1.50, ₹1.00 and ₹1.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹1.50 0.45%
2025-March ₹1.00 0.34%
2024-March ₹1.00 0.15%
2023-March ₹1.00 0.34%
2022-March ₹1.50 0.52%
2021-March ₹2.75 0.81%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹1.00 0.94%
2017-March ₹0.00 0.00%

Bajaj HealthCare Stock Index Membership - Nifty & Sensex

See which indices include Bajaj HealthCare stock. Check BAJAJHCARE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Bajaj HealthCare is not part of any tracked indices.
Only major market indices are tracked in our system.

Bajaj HealthCare Market Events Screener - Corporate Actions

Get Bajaj HealthCare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Bajaj HealthCare stock events that may affect BAJAJHCARE share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 21, 2026, with a record date of September 21, 2026.

It is followed by Dividend dated September 11, 2026 and Quarterly Result Announcement dated July 20, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-21 2026-09-21 Annual General Meeting NA 2.66%
2026-09-11 2026-09-14 Dividend ₹ 1.50 /share -1.72%
2026-07-20 2026-07-20 Quarterly Result Announcement NA 8.98%
2026-05-08 2026-05-08 Quarterly Result Announcement NA 5.56%
2026-01-16 2026-01-16 Quarterly Result Announcement NA -0.57%
2025-10-17 2025-10-17 Quarterly Result Announcement NA 2.25%
2025-09-26 2025-09-26 Annual General Meeting NA 15.00%
2025-09-19 2025-09-19 Dividend ₹ 1.00 /share -26.31%
2025-07-28 2025-07-28 Quarterly Result Announcement NA -0.62%
2025-05-26 2025-05-26 Quarterly Result Announcement NA 1.77%
2025-02-11 2025-02-11 Quarterly Result Announcement NA -5.60%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -8.21%
2024-09-30 2024-09-30 Annual General Meeting NA -0.10%
2024-09-23 2024-09-24 Dividend ₹ 1.00 /share 28.33%
2024-08-07 2024-08-07 Extraordinary General Meeting NA -9.69%

Bajaj HealthCare Competitors Screener - Peer Stocks Comparison

Screen BAJAJHCARE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 441,094 36.44 61,674 12.69% 11,565 40.74
Divis Laboratories 251,970 86.51 11,067 13.95% 2,568 63.87
Torrent Pharmaceuticals 184,688 85.91 13,886 20.34% 2,138 46.50
Zydus Life Science 122,157 26.32 27,658 17.64% 5,026 66.57
Cipla 111,887 33.44 29,045 2.24% 3,870 45.42
Laurus Labs 107,286 99.70 6,868 22.01% 890 64.04
Mankind Pharma 104,566 48.73 14,636 14.85% 1,938 55.24
Dr Reddys Laboratories 103,649 32.05 35,059 3.90% 4,158 63.11
Aurobindo Pharma 98,096 26.36 34,145 5.56% 3,503 54.66
Lupin 94,990 16.99 29,039 26.75% 5,356 35.30

Bajaj HealthCare Company Announcements - News & Reports Screener

Screen BAJAJHCARE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 29, 2026.

The next most recent announcements are dated September 29, 2026 and September 28, 2026.

Date Update Actions
2026-09-29 Closure of Trading Window -
2026-09-29 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-28 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-03 Corporate Action-Record Date For Payment Of Final Dividend -
2026-08-30 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-29 Shareholders Meeting- Dispatch Of Inland Letters To Shareholders -
2026-08-29 Business Responsibility and Sustainability Reporting (BRSR) -
2026-08-29 Reg. 34 (1) Annual Report. -
2026-08-29 Intimation Of 33Rd Annual General Meeting -
2026-08-26 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-21 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-08-12 Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 -
2026-08-06 Announcement under Regulation 30 (LODR)-Credit Rating -
2026-07-27 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-07-22 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-21 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-07-20 Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 -
2026-07-20 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-07-20 Compliances- Statement Of Deviation & Variation -
2026-07-20 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹319.10, within a 52-week range of ₹274.95 to ₹481.00. The P/E ratio is 64.35 and the P/B ratio is 2.13, with earnings per unit of ₹4.98. Market capitalisation stands at ₹1,137.80 Cr and the dividend yield is 0.44%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.